#USA #New York #Class Action #The Gross Law Firm #Alto Neuroscience

Class Action Alert for Alto Neuroscience Shareholders

On September 11, 2025, The Gross Law Firm announced an important notice targeted at shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). If you acquired shares of Alto during the noted period, it's crucial to understand your rights and options in light of a pending class action lawsuit.

Important Details for Shareholders

The Gross Law Firm is reaching out to all individuals and entities who purchased Alto shares within the defined class period, which spans from February 2, 2024, to October 22, 2024. This period also includes stock transactions tied to the company's initial public offering. Those affected are encouraged to consider joining the lawsuit as plaintiffs. While it is advantageous to be a lead plaintiff, it is not a prerequisite to partake in any potential recovery.

Allegations Against Alto Neuroscience

The class action addresses significant issues regarding Alto's product pipeline. Allegations suggest that during the specified timeframe, the company provided materially false or misleading information about its promising product, ALTO-100, which is aimed at treating major depressive disorder. It is asserted that:

1. Ineffectiveness of ALTO-100: The efficacy of ALTO-100 in treating major depressive disorder was overstated, leading to inflated expectations among investors.
2. Overstated Business Prospects: The broader implications for Alto's business, including clinical and regulatory prospects, were misrepresented.
3. Misleading Public Statements: Consequently, the public statements made by the company consistently failed to align with the actual state of its operations and potential.

Registration and Deadlines

For shareholders keen on registering for this class action, it is paramount to act quickly. The deadline for lead plaintiff registration is set for September 19, 2025. Shareholders can register their information through the provided link (
Alto Neuroscience Registration Form). By doing so, they will also benefit from portfolio monitoring software, which will keep them informed about the case's progress.

The Role of The Gross Law Firm

The Gross Law Firm has established itself nationally as a prominent class action law firm dedicated to safeguarding the rights of investors impacted by deceit or fraudulent practices. Their aim is to hold corporations accountable for misleading shareholders, ensuring that ethical business practices are maintained in the corporate sector.

The firm emphasizes its commitment to investors seeking recovery for losses incurred as a result of misleading statements from companies. It is important to note that participation in the case comes without financial obligation.

Contact Information

To further discuss claims, shareholders can reach out to The Gross Law Firm at:

• - Address: 15 West 38th Street, 12th Floor, New York, NY 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

This is a pivotal chance for those impacted by the alleged misleading practices of Alto Neuroscience to seek justice and recovery. Act quickly to ensure your rights are protected and consider participating in this class action lawsuit.